IDEAS home Printed from
   My bibliography  Save this paper

Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward


  • Neri, M.
  • Towse, A.
  • Garau, M.


Multi-indication pricing (MIP) is based on the idea of recognising the value of all the indications, or patient sub-groups, for which a product is authorised. In principle, the implementation of MIP could achieve improvements in both static and dynamic efficiency - prices can be set at a cost-effective level for each indication and patient sub-population, thereby expanding treatment to more patients and stimulating future research as manufacturers anticipate a sufficient return on R&D spending. Despite its theoretical attractiveness, MIP is perceived as entailing a number of challenges and complications over the more widely used single pricing across indications. These include concerns around the appropriation of consumer surplus by manufacturers, leading to higher budget impact as the patient population grows in size, as well as complexity and inadequateness of the health system capabilities required to implement MIP. This report provides a detailed summary of a panel discussion held at the HTAi 2017 annual meeting in Rome on the current approaches to MIP in Europe, the perceived challenges, and how they could be tackled in the future. Erratum - 06/02/2019 - Please note that this copy of the report (originally published 28/11/2018) has been updated to correct an error in Section 3.

Suggested Citation

  • Neri, M. & Towse, A. & Garau, M., 2018. "Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward," Briefings 002084, Office of Health Economics.
  • Handle: RePEc:ohe:briefg:002084

    Download full text from publisher

    File URL:
    Download Restriction: no

    References listed on IDEAS

    1. Berdud, M. & Garau, M. & Neri, M. & O'Neill, P. & Sampson, C. & Towse, A., 2018. "R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C," Research Papers 002040, Office of Health Economics.
    2. Patricia Danzon & Adrian Towse & Jorge Mestre‐Ferrandiz, 2015. "Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 294-301, March.
    3. Cole, A. & Towse, A. & Lorgelly, P. & Sullivan, R., 2018. "Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals," Research Papers 002030, Office of Health Economics.
    4. Mestre-Ferrandiz, J. & Towse, A. & Dellamano, R. & Pistollato, M., 2015. "Multi-indication Pricing: Pros, Cons and Applicability to the UK," Seminar Briefings 001653, Office of Health Economics.
    Full references (including those not matched with items on IDEAS)

    More about this item


    Economics of innovation; Judging value for money and improving decision making;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    NEP fields

    This paper has been announced in the following NEP Reports:


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:briefg:002084. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Publications Manager). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.